ChIP-Seq (chromatin immunoprecipitation sequencing) combines the highly effective chromatin immunoprecipitation (ChIP) methodology and next generation sequencing (NGS) to analyze protein-DNA interactions. These interactions are important for a vast quantity of biological processes involved in normal development and disease progression, such as gene regulation, checkpoint regulation, DNA repair, and DNA synthesis. ChIP-Seq is a valuable tool for discerning and quantifying the specific DNA sequences where proteins bind or epigenetic modifications exist.
Now accepting plant tissue!
Utilizes NGS technology to generate millions of reads across each sample, driving discovery
Offers higher resolution, cleaner data, and the superior ability to identify novel enrichment sites compared to ChIP-array technology
Comprehensive bioinformatics solutions
Selects any chromatin immunoprecipitated protein and modifications for analysis, including transcription factors, structural proteins, protein modifications, and DNA modifications
Low-input DNA requirement
Fast and cost-effective
Azenta Life Sciences, formerly GENEWIZ accepts chromatin immunoprecipitated DNA (ChIP DNA) and plant tissue for ChIP-Seq projects. Please visit our Sample Submission Guidelines page for details.
Azenta is a certified service provider for Illumina NGS platforms and the PacBio Sequel. Please visit our NGS Platforms page for more information.